Two Japanese sibs with X linked agammaglobulinaemia (XLA) were shown to have a new missense mutation, a C to T transition at nucleotide position 1204, resulting in an amino acid change from Leu-358 to Phe in the SH2 domain of Btk (Bruton's tyrosine kinase). The affected leucine in the patients is highly conserved in SH2 domains ofvarious non-receptor tyrosine kinases.
XLA is an inherited immunodeficiency disorder characterised by recurrent bacterial infections, because of antibody deficiency.' Recently, molecular analysis has shown defects in the btk gene in XLA patients. 23 We investigated btk gene defects in two Japanese sibs with XLA, aged 22 (patient 1) and 12 years (patient 2), respectively. The clinical histories and immunological data of the patients have been described previously.45 To determine genetic defects in the patients, we Normal Figure 1 Sequencing of PCR amplified btk cDNA from the patient (left) and a normal control (right). The base substitution mutation at position 1204 of C to T (*) is indicated by the arrow. This mutation resulted in a change of codon 358 CTC for leucine to TTC for phenylalanine.
first analysed an Epstein-Barr virus transformed B lymphoblastoid cell line, K4, derived from bone marrow of patient i' The protein coding region of K4 btk cDNA was amplified in two overlapping regions using reverse transcription PCR as previously described.6 The 5' half of the cDNA synthesised with primer A3 (5'-GGAAATTTGGA-GCCTACTGAG-3') was amplified using primers Al (5'-ACTGAGCACACAGG-TGAAC-3') and B2 (5'-GTGATGAT-GAAGATGGGGCGCT-3'). The primers B4 (5'-AGCTTGGGATTTCCTCTGAG-3'), and B3 (5'-ATTGGCGAGCTCAG-GATTCTTC-3'), described elsewhere,2 were prepared to amplify the remaining region of the molecule. Sequence analysis of the patient's btk cDNA showed a C to T transition at nucleotide position 1204. This would be expected to result in an amino acid change at position 358 from leucine to phenylalanine (fig 1) .
In view of the mutation at a SacI restriction site (GAGCTC to GAGTTC), the region carrying the substitution in the genomic btk DNA was amplified by PCR and then digested with Sacd. Using primers DA2 (5'-CCTCAGAGCCAGTATTACCT-3') and Sad i'-) 1+; We read with interest the report of Vintiner et al' excluding linkage to RARA (17q21), F13A1 (6p24-25), and CRTL1 (5q15) loci in eight multigeneration white families with autosomal dominant non-syndromic cleft lip with or without cleft palate (CL(P)). These candidate genes were chosen on the basis of their mapping close to translocations with associated syndromes which include CL(P), proximity to loci known to cause syndromes which include CL(P), and from previously published association and linkage studies.' We have also tested linkage to the same loci in ten non-syndromic CL(P) white families at these same loci, and can confirm the reported exclusions.' The Pst RFLP in RARA was tested using Southern gel and Genius nonradioactive techniques.2 Tightly linked flanking short tandem repeat PCR markers at the RARA locus, Thral, Mfdl88 (D17S579), D17S800, and Hox2B and CRTL were amplified and separated on 8% sequencing gels,2 and visualised by silver staining using the GELCODE® system.3 Linkage was tested by using MLINK and LIPED, assuming a dominant mode ofinheritance for CL(P) with a penetrance of 0-32 in males and 0-24 in females and with a 0-001 allele frequency. 4 The lod scores at 0=0 were 1-14, -957, -9-72, -8-87, and -2-49 for RARA, Thral, D17S579, D17S800, and Hox2B, respectively. The At 11 months he measured 73 5 cm (50th centile), head circumference was 47 cm (50th centile), and weight was 8300 g (1 0th centile). Psychomotor development has been normal. Both upper limbs were short, the left one more malformed than the right. Both shoulders had normal range of movement. The left upper limb was shorter than the right and kept in a fixed position; there were two digits joined 
